Skip to main content

Is aggressive care appropriate for patients with cancer complicated by pneumonia? A retrospective chart review in a tertiary hospital

Abstract

Background

Pneumonia in cancer patients is often problematic in order to decide whether to admit and administer antibiotics or pursue a comfort care pathway that may avoid in-hospital death. We aimed to identify factors which are easily assessed at admission in Thailand’s healthcare context that could serve as prognostic factors for in-hospital death.

Methods

Regression analysis was utilized to identify the prognostic factors from clinical factors collected at admission. The primary outcome was in-hospital death. Data was collected from the electronic medical records of Chiang Mai University Hospital, Thailand, from 2016 to 2017. Data on adult cancer patients admitted due to pneumonia were reviewed.

Results

In total, 245 patients were included, and 146 (59.6%) were male. The median age of the patients was 66 years (IQR: 57–75). A total of 72 (29.4%) patients died during admission. From multivariate logistic regression, prognostic factors for in-hospital death included: Palliative Performance Scale (PPS) ≤ 30 (OR: 8.47, 95% CI: 3.47–20.66), Palliative Performance Scale 40–50% (OR: 2.79, 95% CI: 1.34–5.81), percentage of lymphocytes ≤ 8.0% (OR: 2.10, 95% CI: 1.08–4.08), and pulse oximetry ≤ 90% (OR: 2.01, 95% CI: 1.04–3.87).

Conclusion

The in-hospital death rate of cancer patients admitted with pneumonia was approximately 30%. The PPS of 10–30%, PPS of 40–50%, percentage of lymphocytes ≤ 8%, and oxygen saturation < 90% could serve as prognostic factors for in-hospital death. Further prospective studies are needed to investigate the usefulness of these factors.

Peer Review reports

Key Statements

What is already known about the topic?

  • - Scoring systems developed specifically for cancer patients require information that may not be available in all Thailand’s hospital settings.

  • - CURB-65 and Pneumonia Severity Index (PSI) for predicting mortality in pneumonia patients usually are not accurate predictors for cancer patients.

What this paper adds

  • - This study found that the Palliative Performance Scale (PPS) ≤ 30%, PPS 40–50%, percentage of lymphocytes ≤ 8.0%, and pulse oximetry ≤ 90% were found to be potential prognostic factors for in-hospital death in this group of patients.

Implications for practice, theory, or policy

  • - This study suggests prognostic factors for guiding management in cancer patients with acute pneumonia, however, prospective studies are needed to confirm this hypothesis.

Background

The prognosis of inevitable death in cancer patients, despite aggressive treatment, is important for decision-making as 70% of Thai people prefer to die at home [1]. The decision not to pursue further aggressive treatment may allow patients to spend their last moments in place where they feel most comfortable.

Pneumonia is one of the most common causes of hospitalization in patients with cancer, and its prognosis differs from that of the general population [2]. In the general population, scoring systems have been developed to predict mortality in patients with pneumonia. Two well-known scoring systems are Pneumonia Severity Index (PSI) [3] and the CURB-65 [4]. The PSI score consists of 20 clinical parameters that may be cumbersome for use in clinical practice, especially in Thailand’s hospital settings. The CURB-65 requires only five clinical parameters, however these scoring systems have not performed well in the cancer population [5, 6]. Some studies have explored other prognostic factors in cancer patients. For example, Ahn et al. [6] found lactic acid levels better at predicting 28-day mortality compared to PSI or CURB-65. However, some of these factors are not routinely assessed in Thai hospitals. For example, lactic acid levels are not usually assessed in pneumonia patients with relatively stable vital signs at admission.

Therefore, our main objective is to identify potential prognostic factors for in-hospital death that are usually assessed at the time of admission in Thailand’s hospital settings. We chose in-hospital death as our outcome because the place of death is a major concern for end-of-life palliative patients. The findings from this study may apply to other low to middle-income countries’ hospital settings as well.

Methods

Study design and population

This was a retrospective cohort study that reviewed data from Chiang Mai University Hospital’s electronic database on adult cancer patients admitted between January 1, 2016, and December 31, 2017. Chiang Mai University Hospital is a 1,400-beds hospital, serves as a tertiary referral center in northern Thailand.

Admissions of patients who were diagnosed with cancer and pneumonia and those greater than 14 years of age were electronically extracted from the electronic medical records. Cancer patient admissions were determined with one of the following the ICD 10 [7]  diagnoses: C00-C96. Pneumonia patient admissions were determined with one of the following ICD 10 diagnoses: J12-J18, J69, and J82. All extracted admissions were manually reviewed by authors (C.A. and T.R.). A patient was considered to have cancer with a histological or cytological confirmation of malignancy before admission. In addition, patients who received cancer treatment before admission, or the latest radiologic image before admission showed evidence of cancerous tissue were also included. A patient was considered to have pneumonia at the time of admission if at least one of the following clinical symptoms was present at the time: cough, fever, sputum production, or pleuritic chest pain, with new lung infiltration on radiological imaging [8].

Admissions that developed pneumonia during admission were excluded. Admissions treated elsewhere for pneumonia before referral to Chiang Mai University Hospital were also excluded. With multiple admissions of the same individual, only the first admission was included. Patients with documentation of advanced care directives before or at the time of admission were also excluded. This was done to ensure that the entry data was relevant to the research question and to minimize the effect of any potential confounders.

During the review process, any disagreement between the authors was settled by discussion until both reached the same conclusion. Unresolved issues were determined by the third author (PG).

Data collection

Factors associated with mortality rates in patients with pneumonia and/or cancer have been reviewed [3, 4, 6, 9,10,11,12]. The factors which can be easily assessed in Thailand’s hospital settings including age, gender, type and stage of cancer, comorbidities (congestive heart failure, cerebrovascular disease, renal disease, and liver disease), vital signs (pulse rate, respiratory rate, blood pressure, body temperature, and oxygen saturation), and state of confusion. Additional data includes the Palliative Performance Scale (PPS), a tool for measuring the performance status of palliative care patients [13], within the first 24 h of admission using the Thai translated version [14]; complete blood count; serum sodium; serum glucose and blood urea nitrogen. The history of non-surgical cancer treatment, including chemotherapy, and/or radiotherapy in chest area within four weeks before admission were also collected. Blood lactic acid levels and arterial pH were not included in this study as they are not accessible in every hospital in Thailand. Status at discharge and length of stay were collected. The electronic records were manually reviewed. All extracted data were anonymized and de-identified before analysis.

Statistical analysis

Patient demographics were descriptively analyzed. Continuous variables were expressed as medians and interquartile ranges (IQR). Categorical variables were expressed as absolute numbers and percentage frequencies. The proportion of in-hospital deaths was calculated. All factors were categorized into categorical variables following previously published studies related to pneumonia mortality [3, 4, 6, 9] before proceeding to univariate logistic regression analysis. PPS were grouped following Clement Ma et al. study [15]. The cutoff point for the percentage of lymphocytes was less than or equal to 8.0%, as this was the median value for the factor in our study. Only factors with a p-value < 0.10 were candidates for multivariate logistic regression analysis. Factors with a p-value > 0.05 were systematically eliminated by the backward stepwise method. A complete case analysis was conducted in this study and missing data were not imputed. Factors with missing data of more than 20% were excluded from the analysis. Model goodness-of-fit was tested with the Hosmer-Lemeshow test. A two-tailed p-value of less than 0.05 was considered statistically significant. Stata version 15.1 was used for the statistical analysis. The overview of the study methodology is shown in Fig. 1.

Fig. 1
figure 1

Inclusion and exclusion flow diagram

Results

Baseline characteristics

A total of 245 patients were included in the analysis with a median patient age of 66 years (IQR 57–75), of which 146 were male patients (59.6%). Of these cases, 195 (79.6%) patients had solid tumor, 48 (19.6%) had hematologic malignancy and 2 (0.8%) had metastatic cancer without tissue confirmation of the origin of cancer. Of all the included patients, only 184 had documentation of cancer staging during their admission. There are 4 patients in Stages 1, 4 patients in stage 2, 18 patients in Stage 3, 142 patients in Stage 4, 4 patients were documented as advanced cancer, and 12 were documented as recurrent/relapse of cancer. The four most diagnosed cancers were malignant neoplasms of the respiratory and intrathoracic organs (96 patients, 39.2%); malignant neoplasms of lymphoid, hematopoietic, and related tissue (48 patients, 19.6%); malignant neoplasms of the digestive organs (35 patients, 14.3%); and malignant neoplasms of the lip, oral cavity, and/or pharynx (14 patients, 5.7%).

In-hospital death rate

Of the 245 patients, 173 were alive at the time of discharge, and 72 died during the hospital stay. The in-hospital mortality rate was calculated to be 29.4% (95% CI: 24.0-35.4%). The median lengths of stay for patients who were alive at the time of discharge was nine days (IQR: 6–14), those who died in hospital had a median stay of eight days (IQR: 4-16.5). The general characteristics of the patients are shown in Table 1.

Table 1 General population characteristics

Factors associated with mortality rate during admission

For the univariate logistic regression analysis, we combined patients with PPS 60–70, 80–90, and 100 together. Seven factors were identified to have p-values below 0.10, as follows: pulse oximetry ≤ 90% (OR: 2.37, 95% CI: 1.32–4.28), respiratory rate ≥ 30 per minute (OR: 2.70, 95% CI: 1.50–4.86), PPS 40–50 (OR: 3.52, 95% CI: 1.77-7.00), PPS 10–30 (OR: 9.51, 95% CI: 4.17–21.69), percentage of lymphocytes ≤ 8.0% (OR: 2.34, 95% CI: 1.33–4.15), BUN ≥ 20 mg/dL (OR: 2.22, 95% CI: 1.14–4.32), and history of chemotherapy within four weeks (OR: 0.39, 95% CI: 0.17–0.88). The results are shown in Table 2.

Table 2 Univariate logistic regression analysis

All seven factors were entered into the multivariate logistic regression analysis. Factors were eliminated using backward elimination techniques at a p-value of > 0.05. The following four factors were found to be associated with in-hospital death rates: PPS 40–50 (OR: 2.79, 95% CI: 1.34–5.81), PPS ≤ 30 (OR: 8.47, 95% CI: 3.47–20.66), percentage of lymphocytes ≤ 8.0% (OR: 2.10, 95% CI: 1.08–4.08), and pulse oximetry ≤ 90% (OR: 2.01, 95% CI: 1.04–3.87) as seen in Table 3. The Hosmer-Lemeshow test indicated a well-fitted model (p-value 0.841).

Table 3 Multivariate logistic regression analysis

Discussion

In this study, the in-hospital death rate of cancer patients who were admitted with pneumonia between January 1, 2016, and December 31, 2017, was 29.4%. This rate is considered clinically high.

Similar studies by Gonzalez et al. [5] and Ahn et al. [6] found the 30- and 28-day mortality rates were 20.2% and 19.3%, respectively. Although the definition of mortality rate in this study was different from Gonzalez et al. and Ahn et al.‘s studies, they are roughly comparable. In this study more than 94% of the population were discharged within 28 days of admission, and our mortality rate did not account for patients who died after discharge. If we compare mortality rates using 28-day mortality rate definition, 29.39% would be an underestimation. A possible explanation for the large difference between studies is that ours only included admitted patients, whereas the other studies included outpatient cases as well. In addition, most of the patients included in our study had advanced cancer.

The four factors associated with the in-hospital death rate for cancer patients admitted with pneumonia were: PPS at 40–50%, PPS at 10–30%, percentage of lymphocytes ≤ 8.0%, and oxygen saturation ≤ 90%. Patient confusion was a factor that could not be assessed due to incomplete information in our electronic database.

The association between patient’s performance status and in-hospital mortality in our study was similar to Ahn et al.‘s study, [6] which also found that poor performance status was associated with the mortality rate. Although the Eastern Cooperative Oncology Group (ECOG) scale [16] was used to assess performance status in Ahn et al.‘s study, the ECOG and PPS can be used interchangeably [15, 17] PPS is a tool that is useful in estimating survival time in cancer patients [12]. The direction of association between PPS and the in-hospital mortality found in this study is also similar to the association between PPS and survival time observed in cancer patients.

The association between oxygen saturation and in-hospital mortality found in our study was also similar to Ahn et al.‘s [6] study. Oxygen saturation represents the ability of the lungs to oxygenate the blood. Low oxygen saturation is indicative of impaired lung function [18]. In this study population, impaired oxygen saturation would indicate severe pneumonia with a greater likelihood of death during the hospital stay.

Lymphocyte was found to be an important factor associated with the in-hospital mortality in this study. This finding is similar to Zhao et al. report [11]. Lymphocyte is a type of white blood cell responsible for reinforcing the immune system to fight infections [19, 20]. Moreover, lymphocytes are among the primary white blood cells to inhibit and kill cancer cells [20, 21]. Hence, they are important to the survivability of patients in this study. A decreased number of lymphocytes in cancer patients can be due to malnutrition, [22, 23] possibly due to the presence of cancer itself. Some cancer treatments can also decrease the number of lymphocytes, [24, 25] such as, radiation therapy and chemotherapy, making the body susceptible to numerous infectious attacks.

This study did not find a statistically significant association between the age of more than 65 years and the in-hospital mortality. However, studies have found that an age of more than 65 years was associated with mortality in the general population with pneumonia [3, 4]. Cancer treatments and cancer itself can weaken the immune system and overall body function [24, 25]. This process might be more pronounced than the effects of aging in the population with cancer, which may explain why age was not found to be associated with the in-hospital mortality in this study.

BUN level was found to be associated with the in-hospital mortality in the univariate logistic regression analysis but not in multivariate analysis. Ugajin et al. [26] proposed that the elevation of BUN levels in patients with pneumonia is probably due to dehydration. Under such conditions, the kidneys reabsorb urea along with water, which ultimately causes an elevation in BUN levels. However, in cancer population, performance status, lymphocytes, and oxygen saturation may be factors that are more closely associated to the mortality that attenuate association of BUN level.

Limitations

This was a retrospective observational study done in a tertiary hospital in Chiang Mai as this study included large proportion of patients with advanced cancer it may skew the findings. This may limit the generalizability of our findings. Further studies are needed for external validation.

We used in-hospital death as our primary outcome while other studies focused on an overall 28-day mortality rate. In addition, consciousness and cancer staging were not included in our analysis model due to the high proportion of missing data. We also did not include chest x-rays findings in our study. Caution should be made when comparing this study’s results with others.

Conclusion

In this study, the in-hospital death rate of cancer patients admitted with pneumonia was approximately 30%. The factors associated with the in-hospital death rate were PPS 10–30% and 40–50%, percentage of lymphocytes ≤ 8%, and oxygen saturation < 90%. These factors can easily be assessed in the Thailand’s hospital setting. The results of this study may be helpful in prognosis discussions for advanced cancer patients admitted with pneumonia.

Availability of data and materials

The datasets generated during and analyzed during the current study are available from the corresponding author upon reasonable request.

References

  1. Chindaprasirt J, Wongtirawit N, Limpawattana P, et al. Perception of a “good death” in Thai patients with cancer and their relatives. Heliyon. 2019;5(7).

    Article  Google Scholar 

  2. Rabello LSCF, Silva JRL, Azevedo LCP, et al. Clinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study. Efron PA, editor. PLoS ONE. 2015;10(3):e0120544.

    Article  Google Scholar 

  3. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;23(4):243–50.

    Article  Google Scholar 

  4. Lim WS. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–82.

    Article  CAS  Google Scholar 

  5. Gonzalez C, Johnson T, Rolston K, et al. Predicting pneumonia mortality using CURB-65, PSI, and patient characteristics in patients presenting to the emergency department of a comprehensive cancer center. Cancer Med. 2014;3(4):962–70.

    Article  Google Scholar 

  6. Ahn BK, Lee Y-S, Kim Y-J, et al. Prediction model for mortality in cancer patients with pneumonia: comparison with CURB-65 and PSI. Clin Respir J. 2018;12(2):538–46.

    Article  Google Scholar 

  7. ICD-10 Version. :2016. Available from: https://icd.who.int/browse10/2016/en (2016, Accessed 20 Mar 2022)

  8. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired Pneumonia: diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention. Am J Respir Crit Care Med. 2001;163(7):1730–54.

    Article  CAS  Google Scholar 

  9. This study was organised by a subcommittee of the Research Committee of the British Thoracic Society and the Public Health Laboratory Service. Community-acquired Pneumonia in Adults in British Hospitals in 1982–1983: A Survey of Aetiology, Mortality, Prognostic Factors and Outcome. QJM. 1987;62(3):195–220.

    Article  Google Scholar 

  10. Jeon K, Yoo H, Jeong B-H, et al. Functional status and mortality prediction in community-acquired pneumonia: functional status and mortality in CAP. Respirology. 2017;22(7):1400–6.

    Article  Google Scholar 

  11. Zhao W, Wang P, Jia H, et al. Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care? BMC Cancer. 2017;17(1):514.

    Article  Google Scholar 

  12. Simmons CPL, McMillan DC, McWilliams K, et al. Prognostic tools in patients with Advanced Cancer: a systematic review. J Pain Symptom Manag. 2017;53(5):962-970e10.

    Article  Google Scholar 

  13. Anderson F, Downing GM, Hill J, et al. Palliative Performance Scale (PPS): a New Tool. J Palliat Care. 1996Mar;12(1):5–11.

    Article  CAS  Google Scholar 

  14. Chewaskulyong B, Sapinun L, Downing GM, et al. Reliability and validity of the Thai translation (Thai PPS Adult Suandok) of the Palliative Performance Scale (PPSv2). Palliat Med. 2012;26(8):1034–41.

    Article  Google Scholar 

  15. Ma C, Bandukwala S, Burman D, et al. Interconversion of three measures of performance status: an empirical analysis. Eur J Cancer. 2010;46(18):3175–83.

    Article  Google Scholar 

  16. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

    Article  CAS  Google Scholar 

  17. de Kock I, Mirhosseini M, Lau F, et al. Conversion of Karnofsky Performance Status (Kps) and Eastern Cooperative Oncology Group Performance Status (Ecog) to Palliative Performance Scale (Pps), and the interchangeability of Pps and Kps in Prognostic Tools. J Palliat Care. 2013;29(3):163–9.

    Article  Google Scholar 

  18. Hafen BB, Sharma S. Oxygen Saturation. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 Mar 20]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK525974/

  19. Nicholson LB. The immune system. Essays Biochem. 2016;60(3):275–301.

    Article  Google Scholar 

  20. Delves PJ, Martin SJ, Burton DR, et al. Roitt’s essential immunology. 13th edition. Chichester, West Sussex; Hoboken, [N.J.]: Wiley Blackwell; 2017. p. 576.

    Google Scholar 

  21. Pardoll D. Cancer and the Immune System: Basic Concepts and Targets for Intervention. Sem Oncol. 2015;42(4):523–38.

    Article  CAS  Google Scholar 

  22. Ota Y, Ishihara S, Otani K, et al. Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes. Mol Clin Oncol. 2016;4(4):607–10.

    Article  CAS  Google Scholar 

  23. Alwarawrah Y, Kiernan K, MacIver NJ. Changes in Nutritional Status Impact Immune Cell metabolism and function. Front Immunol. 2018;16(9):1055.

    Article  Google Scholar 

  24. Grossman SA, Ellsworth S, Campian J, et al. Survival in patients with severe Lymphopenia following treatment with Radiation and Chemotherapy for newly diagnosed solid tumors. J Natl Compr Canc Netw. 2015;13(10):1225–31.

    Article  CAS  Google Scholar 

  25. Wang Q, Li S, Qiao S, et al. Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis. Front Immunol. 2021;12.

    Article  CAS  Google Scholar 

  26. Ugajin M, Yamaki K, Iwamura N, et al. Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community-acquired pneumonia. IJGM. 2012;5:583–9.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Dr. Bussayamas Cheewasakulyong for her valuable suggestion regarding oncological grading status.

Funding

The Faculty of Medicine Chiang Mai University provided a grant for the accepted publication page charge.

Author information

Authors and Affiliations

Authors

Contributions

C.A. and P.G wrote the main manuscript, and T.R. helped in refining tables and figures. All authors reviewed the manuscript. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Patama Gomutbutra.

Ethics declarations

Ethics approval and consent to participate

Ethics approval for this study was obtained from the Research Ethics Committee 4, Faulty of Medicine, Chiang Mai University, Chiang Mai, Thailand (STUDY CODE: FAM-2560-05198). The study had been granted ethics committee approval prior to commencing. All methods were carried out in accordance with relevant guidelines and regulations. This retrospective chart review study was considered by the expedited process. The informed consent form was waived due to the research involved no more minimal risk. The Research Ethics Committee 4, Faulty of Medicine, Chiang Mai University, Chiang Mai, Thailand, waived the requirement of informed consent.

Consent for publication

Not applicable.

Competing interests

All the authors have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Aramrat, C., Ratanasiri, T. & Gomutbutra, P. Is aggressive care appropriate for patients with cancer complicated by pneumonia? A retrospective chart review in a tertiary hospital. BMC Palliat Care 22, 3 (2023). https://doi.org/10.1186/s12904-023-01127-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12904-023-01127-2

Keywords

  • Cancer
  • Pneumonia
  • In-hospital mortality rate
  • Prognosis
  • Lymphocyte
  • Oxygen pulse